[EASL2015]第50届欧洲肝脏研究学会（EASL）年会亮点预告

　　2015年4月22~26日，第50届欧洲肝脏研究学会（EASL）年会暨国际肝脏大会（The International Liver Congress™，ILC 2015）将在奥地利维也纳举行。

　　今年EASL创建已历经50载，会议主办方将隆重纪念这一历史性时刻，与此同时，也热烈祝贺学会期刊Journal of Hepatology杂志在最新公布的影响因子破10--在肝病领域杂志中名列前茅！

　　大会名誉主席Serge Erlinger教授介绍道，“维也纳是ILC 2015举办最理想的城市。在这里，诞生了被誉为‘现代肝病学之父’的汉斯·波普尔（Hans Popper，1903~1988年）--世界著名的肝病学家与病理学家，肝病学领域的重要奠基人之一，他筹建了美国肝病研究学会（AASLD）和国际肝病学会。我相信本届大会将取得一个巨大的成功！”

　　2015/4/22 星期三

8:00 - 8:30 Joint Workshop: ILC Viral Hepatitis Workshop

　　●Is HBV infection curable? Fabien Zoulim, France

　　●Challenge: the HCC epidemics in ?cured? hepatitis patients Jordan Feld, Canada

　　●HCV treatment to PWID-results from the ACTIVATE trial Stéphane Chevaliez, France

10:00 - 10:15 Joint Workshop: EASL-Public Health CAG

　　●Current and future options to treat high risk groups and difficult to treat patients: Chronic HBV Maurizia Brunetto, Italy

　　●Current and future options to treat high risk groups and difficult to treat patients: Chronic HCV Jason Grebely, Australia

　　●Prospects for an effective HCV vaccine Thomas Baumert, France

11:30 - 17:30 Post-Graduate Course--Metabolic Liver

　　2015/4/23 星期四

10:30 - 12:00 Basic Science Seminar - Liver Tumours Microenvironment and therapy

　　●The inflammatory response and its consequences - can we intervene? Derek Mann, The United Kingdom

　　●The role of neutrophils in HCC Caroline Wilson, The United Kingdom

　　●Oncolytic viral therapy Oliver Ebert, Germany

　　●Targeting, delivery and imaging of oncolytic virotherapeutics Jennifer Altomonte, Germany

　　●Immunotherapy for HCC? David Adams, The United Kingdom

　　●Immune responses to hepatocellular carcinoma: complex regulation and therapeutic potential Ka-Kit Li, The United Kingdom

　　2015/4/24 星期五

7:30 - 8:30 Early Morning Workshops

　　Endpoints for antifibrotic trials: what does it take to be a game changer? Moderators: Veronica Miller, The United States；Detlef Schuppan, Germany

10:30 - 11:00 J.P. Benhamou State of the Art Session

　　Iron and the liver…of pathogens, metabolic adaptation and human disease Antonello Pietrangelo, Italy

12:45-13:45 EASL Recommendations on treatment of hepatitis C 2015

14:55 - 15:20 Clinical Symposium

　　PBCShould we treat PBC as an autoimmune disease? Gideon Hirschfield, The United Kingdom

　　2015/4/25 星期六

10:30 - 11:00 State of the Art Session - Basic Science

　　Reengineering the microenvironment to improve treatment of fibrotic diseases Rakesh Jain, The United States

14:00-15:30 Clinical Symposium HBVFuture of HBV treatments

　　●The current treatment situation and definitions of a cure for chronic HBV infection Geoffrey Dusheiko, The United Kingdom

　　●The main unresolved questions to cure HBV infection Ulrike Protzer, Germany

　　●The new direct antivirals in pre-clinical and early clinical development Fabien Zoulim, France

　　●Novel concepts of immune therapy (restoration of innate and/or adaptive immune responses) Antonio Bertoletti, Singapore

　　2015/4/26 星期日

7:30 - 8:30 WHO Global Hepatitis Strategy in the makingGottfried Hirnschall, Switzerland

08:30 - 10:00 30 Years of Journal of Hepatology: Emerging issues in HepatologyRajiv Jalan, The United Kingdom

　　敬请期待《国际肝病》微信同步报道，更多精彩内容也将在国际肝病网站专题海量呈现！

（来源：《国际肝病》编辑部）